검색
AIM ImmunoTech Inc
AIM관심 목록에 추가
0.279USD
-0.017-5.84%
종가 06/30, 16:00（ET）시세는 15분 지연됩니다
2.29M시가총액
손실P/E TTM
자세한 내용은 AIM ImmunoTech Inc 회사
AIM ImmunoTech Inc. is an immuno-pharma company. The Company is focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders and viral diseases, including COVID-19. The Company’s flagship products are Ampligen (rintatolimod) and Alferon N Injection (Interferon alfa). Ampligen is a double-stranded RNA (dsRNA) and highly selective TLR3 agonist immuno-modulator, which is being developed for globally important cancers, viral diseases and disorders of the immune system. Ampligen is approved for commercial sale in the Argentine Republic for the treatment of severe chronic fatigue syndrome (CFS). Alferon N Injection is an injectable formulation of natural alpha interferon, which is approved for sale in the United States and Argentina for the intralesional treatment of refractory or recurring external genital warts in patients 18 years of age or older.
AIM ImmunoTech Inc 정보
종목 코드 AIM
회사 이름AIM ImmunoTech Inc
상장일Jul 12, 1996
CEOEquels (Thomas K)
직원 수21
유형Ordinary Share
회계 연도 종료Jul 12
주소2117 Sw Highway 484
도시OCALA
증권 거래소NASDAQ OMX – NASDAQ Basic Amex
국가United States of America
우편 번호32801
전화13524487797
웹사이트https://aimimmuno.com/
종목 코드 AIM
상장일Jul 12, 1996
CEOEquels (Thomas K)
AIM ImmunoTech Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Thomas K. Equels, Esq., J.D.
Mr. Thomas K. Equels, Esq., J.D.
President, Chief Executive Officer, Executive Vice Chairman of the Board
President, Chief Executive Officer, Executive Vice Chairman of the Board
63.92K
+39.13%
Mr. David I. Chemerow
Mr. David I. Chemerow
Independent Director
Independent Director
28.44K
+97.74%
Dr. William M. Mitchell, M.D., Ph.D.
Dr. William M. Mitchell, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
5.22K
+0.04%
Ms. Nancy K. Bryan
Ms. Nancy K. Bryan
Independent Director
Independent Director
2.92K
-0.03%
Mr. Robert (Rob) Dickey, IV
Mr. Robert (Rob) Dickey, IV
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter W. Rodino, III
Mr. Peter W. Rodino, III
Chief Operating Officer, Executive Director - Governmental Relations, General Counsel, Company Secretary
Chief Operating Officer, Executive Director - Governmental Relations, General Counsel, Company Secretary
--
--
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Mr. Ted D. Kellner
Mr. Ted D. Kellner
Independent Director
Independent Director
--
--
이름
이름/직위
직위
주식 보유
변동
Mr. Thomas K. Equels, Esq., J.D.
Mr. Thomas K. Equels, Esq., J.D.
President, Chief Executive Officer, Executive Vice Chairman of the Board
President, Chief Executive Officer, Executive Vice Chairman of the Board
63.92K
+39.13%
Mr. David I. Chemerow
Mr. David I. Chemerow
Independent Director
Independent Director
28.44K
+97.74%
Dr. William M. Mitchell, M.D., Ph.D.
Dr. William M. Mitchell, M.D., Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
5.22K
+0.04%
Ms. Nancy K. Bryan
Ms. Nancy K. Bryan
Independent Director
Independent Director
2.92K
-0.03%
Mr. Robert (Rob) Dickey, IV
Mr. Robert (Rob) Dickey, IV
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Peter W. Rodino, III
Mr. Peter W. Rodino, III
Chief Operating Officer, Executive Director - Governmental Relations, General Counsel, Company Secretary
Chief Operating Officer, Executive Director - Governmental Relations, General Counsel, Company Secretary
--
--
자주 묻는 질문
AIM ImmunoTech Inc의 상위 5대 주주는 누구인가요?
AIM ImmunoTech Inc의 상위 5대 주주는 다음과 같습니다: Mr. Thomas K. Equels, Esq., J.D.
AIM ImmunoTech Inc(AIM)의 주식을 보유한 기관은 몇 개입니까?
2026Q1 기준으로, AIM ImmunoTech Inc의 주식을 보유한 기관은 총 57곳이며, 이들이 보유한 주식의 총 가치는 약 105.74K로 전체 발행 주식의 1.30%를 차지합니다. 이는 2025Q4 대비 -74291.00 증가한 수치입니다.
